Schweizer, Edward

The researcher's own therapy allegiances: A "wild card" in comparisons of treatment efficacy.

Luborsky, L., Diguer, L., Seligman, D. A., Rosenthal, R., Krause, E. D., Johnson, S., Halperin, G., Bishop, M., Berman, J. S., & Schweizer, E. (1999) · Clinical Psychology: Science and Practice

Psychotherapy Techniques and ApplicationsMeta-analysis and systematic reviews

Cited by 572

Long-term Therapeutic Use of Benzodiazepines: II. Effects of Gradual Taper

Schweizer, E. (1990) · Archives of General Psychiatry

Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Cited by 191

Efficacy and Safety of Fluoxetine in Treating Bipolar II Major Depressive Episode

Amsterdam, J. D., Garcia-Espana, F., Fawcett, J., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., Schweizer, E., & Beasley, C. (1998) · Journal of Clinical Psychopharmacology

Bipolar Disorder and TreatmentTreatment of Major Depression

Cited by 167

Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management

Schweizer, E., & Rickels, K. (1998) · Acta Psychiatrica Scandinavica

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSubstance Abuse Treatment and Outcomes

Cited by 163

Carbamazepine Treatment in Patients Discontinuing Long-term Benzodiazepine Therapy: Effects on Withdrawal Severity and Outcome

Schweizer, E. (1991) · Archives of General Psychiatry

Substance Abuse Treatment and OutcomesEpilepsy research and treatment

Cited by 138

Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine

Schweizer, E. (1993) · Archives of General Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Treatments and Disorders

Cited by 120

Long-term benzodiazepine users 3 years after participation in a discontinuation program

Rickels, K., CASE, W. G., Schweizer, E. E., España, F. G., & Fridman, R. (1991) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesPharmaceutical Practices and Patient Outcomes

Cited by 87

Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial

Hadley, S. J., Mandel, F. S., & Schweizer, E. (2012) · Journal of Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 66

The Effect of Personality on Withdrawal Severity and Taper Outcome in Benzodiazepine Dependent Patients

SCHWEIZER, E., RICKELS, K., De MARTINIS, N., CASE, G., & GARCÍA-ESPAÑA, F. (1998) · Psychological Medicine

Substance Abuse Treatment and OutcomesPersonality Disorders and Psychopathology

Cited by 60

Psychomotor Performance of Long-Term Benzodiazepine Users Before, During, and After Benzodiazepine Discontinuation

Rickels, K., Lucki, I., Schweizer, E., Garcia-Espana, F., & Case, W. G. (1999) · Journal of Clinical Psychopharmacology

Pharmaceutical Practices and Patient OutcomesSubstance Abuse Treatment and Outcomes

Cited by 49

Imipramine and Buspirone in Patients With Panic Disorder Who Are Discontinuing Long-term Benzodiazepine Therapy

Rynn, M., García-España, F., Greenblatt, D. J., Mandos, L. A., Schweizer, E., & Rickels, K. (2003) · Journal of Clinical Psychopharmacology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesCardiac Health and Mental Health

Cited by 23

The Drug Treatment of Anxiety and Panic Disorder

Rickels, K., Case, W. G., & Schweizer, E. (1988) · Stress Medicine

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Cited by 6